Image de couverture de livre

Exploring Providers' Behaviors, Attitudes, and Preferences on the Treatment of Pulmonary Arterial Hypertension With Endothelin Receptor Antagonist (ERA) + Phosphodiesterase‐5 Inhibitors (PDE5i)

Fuente: Wiley Open Access

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Nicholas A. Kolaitis, Martha Kingman, Melisa Wilson, Gabriela Gomez Rendon, David Lopez, Carly J. Paoli, Mohammad Rahman, Ashley Martin, November McGarvey, Abraham Lee, Lana Melendres‐Groves
Format:	Artículo Open Access
Publié:	Wiley 2025
Sujets:	Pulmonary Circulation
Accès en ligne:	Acceder al recurso
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Qualitative Interviews of Physicians Managing Patients With Methamphetamine‐Associated Pulmonary Arterial Hypertension: Understanding the Unmet Medical Needs From a Provider Lens
par: John F. Kingrey, et autres
Publié: (2026)

Prognosis and Treatment With Phosphodiesterase 5 Inhibitors in Combined Post‐ and Precapillary Pulmonary Hypertension: A Propensity Score‐Matched Analysis From the Hellenic Pulmonary Hypertension Registry
par: Georgios E. Papadopoulos, et autres
Publié: (2025)

The Role of the Cellular Communication Network Protein Family in Pulmonary Arterial Hypertension
par: Carly E. Byrd, et autres
Publié: (2026)

Prevalence and Economic Burden of Pulmonary Hypertension and Pulmonary Arterial Hypertension Among the Medicaid Population
par: Marshaleen Henriques King, et autres
Publié: (2025)

Prognostic Role of Platelets in Pulmonary Arterial Hypertension
par: Caio Julio Cesar dos Santos Fernandes, et autres
Publié: (2025)

Heart Rate Variability in Pulmonary Arterial Hypertension
par: Bishal Gyawali, et autres
Publié: (2025)

A Systematic Literature Review Exploring the Efficacy and Safety of Tadalafil and Sildenafil in Pulmonary Arterial Hypertension
par: Rajan Saggar, et autres
Publié: (2025)

Patient Perspectives on Fixed Dose Combination Therapy for Pulmonary Arterial Hypertension: Exploratory Focus Group Research
par: Jean M. Elwing, et autres
Publié: (2025)

Melatonin in Pulmonary Arterial Hypertension: A Promising Adjunctive Therapy
par: Shaher Yar, et autres
Publié: (2025)

Supplemental Oxygen Decreases Cardiac Effort in Pulmonary Arterial Hypertension
par: Kyle Norton, et autres
Publié: (2026)

Assessing the Impact of Time to Diagnosis and Treatment for Patients With Pulmonary Arterial Hypertension
par: Hilary M. DuBrock, et autres
Publié: (2025)

Towards a Safe Pathway to Biological Parenthood for Pulmonary Arterial Hypertension
par: Jamie D. Ingram, et autres
Publié: (2026)

Risk Assessment Models and Event‐Free Survival in Pulmonary Arterial Hypertension
par: Clara Hjalmarsson, et autres
Publié: (2025)

Balancing Risk and Hope: Insights Into Pregnancy Outcomes in Pulmonary Arterial Hypertension
par: Teresa Segura de la Cal, et autres
Publié: (2026)

Association of Immunoglobulin E With Right Ventricular Dysfunction in Pulmonary Arterial Hypertension
par: Fengxia Wu, et autres
Publié: (2026)

Pulmonary Arterial Wedge Oxygen Saturation: Does It Confirm Wedge Position in Patients With Pulmonary Hypertension?
par: Ambalavanan Arunachalam, et autres
Publié: (2025)

Methamphetamine‐Associated Pulmonary Arterial Hypertension: Impact, Mechanisms, and a Framework for Management
par: Namita Sood, et autres
Publié: (2026)

Identification of Diagnostic Biomarkers Causally Associated With Gut Microbiota and Pulmonary Arterial Hypertension
par: Ming Sun, et autres
Publié: (2025)

How a Most Unlikely Drug Changed the Outcome of Pulmonary Arterial Hypertension
par: Ivan M. Robbins, et autres
Publié: (2025)

Programmatic Approach to Outpatient Cardiac Catheterization in Children With Stable Pulmonary Arterial Hypertension
par: Gregory T. Adamson, et autres
Publié: (2025)

Melatonin Improves Quality of Life, Oxidative Stress, and Cardiovascular Function in Pulmonary Arterial Hypertension
par: Alicia de la Fuente, et autres
Publié: (2025)

Assessment of the Relationship Between the Six‐Minute Walk Test (6MWT) With Serum Chloride Level and Mean Pulmonary Arterial Pressure in Patients With Pulmonary Arterial Hypertension
par: Sepideh Hejazi, et autres
Publié: (2025)

The Role of Telehealth in PAH Management: Benefits, Barriers, and Solutions
par: Susanne McDevitt, et autres
Publié: (2025)

American Lung Association Pulmonary Hypertension Roundtable: Executive Summary
par: Nicholas Andreas Kolaitis, et autres
Publié: (2025)

Repair of Sinus Venosus Atrial Septal Defect in 2 Patients With Severe Pulmonary Arterial Hypertension
par: Ryo Sakuma, et autres
Publié: (2026)

Developing Benchmarks in the Diagnosis and Treatment of Pulmonary Arterial Hypertension in a Tertiary, Academic Medical Center
par: Cyrus A. Kholdani, et autres
Publié: (2025)

Plasma GDF‐15 and PSP‐D Predict the Development of Pulmonary Arterial Hypertension in Systemic Sclerosis
par: Adam Engel Sällberg, et autres
Publié: (2026)

Why Wait for Sick People to Get Sicker? The Paradox of the Treatment of Patients With Pulmonary Arterial Hypertension
par: Mauricio Orozco‐Levi, et autres
Publié: (2025)

Real‐World Dosing and Persistence of Oral Treprostinil Initiation Strategies in Patients With Pulmonary Arterial Hypertension
par: Daniel J. Lachant, et autres
Publié: (2025)

Sotatercept for Decompensated Pulmonary Arterial Hypertension Requiring VA ECMO: First Canadian ICU Experience
par: Jonathan Taylor, et autres
Publié: (2026)

Role of a New Walk Test in Pulmonary Arterial Hypertension: A Retrospective Cohort Study
par: Junhao Jin, et autres
Publié: (2025)

Lifesaving Compassionate‐Use of Sotatercept in a 12‐Year‐old With Idiopathic Pulmonary Arterial Hypertension
par: Weronika Pelczar‐Płachta, et autres
Publié: (2026)

Sotatercept to Wean Off Prostacyclin Infusion Therapy for Pulmonary Arterial Hypertension: A Case Report
par: Daniel J. Strick, et autres
Publié: (2025)

Comparing Pulmonary Arterial Hypertension Care in Urban and Rural Settings: Treatment Patterns and Risk Trajectories
par: Amrit K. Deol, et autres
Publié: (2025)

Societal Costs Associated With Pulmonary Arterial Hypertension Subgroups: A Study Utilizing Linked National Registries
par: Barbro Kjellström, et autres
Publié: (2025)

Performance of Risk‐Stratification Scores for Patients With Pulmonary Arterial Hypertension in a Multi‐Ethnic Asian Population
par: Haowen Jiang, et autres
Publié: (2024)

Flow Cytometric Determination of Circulating Progenitor Cells in Patients With Pulmonary Arterial Hypertension: A Systematic Review
par: Kimia Heydari, et autres
Publié: (2025)

Identification of RUNX1 as a Biomarker for Right Ventricular Remodeling in Pulmonary Arterial Hypertension Using WGCNA
par: Wenjie Chen, et autres
Publié: (2026)

History of Adverse Pregnancy Outcomes in Women With Pulmonary Arterial Hypertension: A Single‐Center Pilot Study
par: Jessica B. Badlam, et autres
Publié: (2025)

Comorbidities and Events of Clinical Interest in Patients with Pulmonary Arterial Hypertension (PAH): Analysis of Real‐World Data
par: Julia R. DiBello, et autres
Publié: (2026)